[Skip to Content]
[Skip to Content Landing]
Article
August 1981

Lipoproteins, Cardiovascular Disease, and DeathThe Framingham Study

Author Affiliations

From the National Heart, Lung, and Blood Institute, Bethesda, Md (Mr Gordon and Dr Castelli); Framingham Heart Study, Framingham, Mass (Dr Castelli); Section of Preventive Medicine and Epidemiology, Boston University School of Medicine (Drs Kannel and Dawber); and the Evans Research Foundation, Boston (Drs Kannel and Dawber). Mr Gordon is retired and is a consultant biometrician.

Arch Intern Med. 1981;141(9):1128-1131. doi:10.1001/archinte.1981.00340090024008
Abstract

• Based on six years of follow-up evaluations of the Framingham, Mass, men and women aged 49 to 82 years, it was found that a low-density lipoprotein (LDL) cholesterol concentration was associated with a low incidence of coronary heart disease (CHD) risk but with a statistically significant excess of stroke incidence in women and of deaths from non-CHD causes in both sexes. There was no suggestion that an elevated HDL cholesterol level was associated with an excess incidence of any of the cardiovascular end points considered or of death. An inverse relation of high-density lipoprotein (HDL) cholesterol level with CHD and its major consequences, CHD death and congestive heart failure, was observed. Triglyceride determinations seem to add little information respecting cardiovascular risk to that elicited from HDL and LDL cholesterol and other known cardiovascular risk factors. While the relation of HDL and LDL cholesterol with CHD is paralleled by findings from a variety of sources, the inverse relation of LDL cholesterol with stroke in women and with death from non-CHD causes requires additional confirmation and exploration.

(Arch Intern Med 1981;141:1128-1131)

References
1.
Kannel WB, Castelli WP, Gordon T, et al:  Serum cholesterol, lipoproteins and risk of coronary heart disease: The Framingham Study. Ann Intern Med 1971;74:1-12.Article
2.
Gordon T, Castelli WP, Hjortland MC, et al:  High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977;62:707-714.Article
3.
Kannel WB, Garcia MJ, McNamara PM, et al:  Serum lipid precursors of coronary heart disease. Human Pathol 1971;2:129-151.Article
4.
Kannel WB:  Lipid profile and the potential coronary victim. Am J Clin Nutr 1971;24:1074-1081.
5.
Kannel WB, Dawber TR, Friedman GD, et al:  Risk factors in coronary heart disease: An evaluation of several serum lipids as predictors of coronary heart disease. Ann Intern Med 1964;61:888-899.Article
6.
Wilhelmsen L, Wedel H, Tibblin G:  Multivariate analysis of risk factors for coronary heart disease. Circulation 1973;48:950-958.Article
7.
Rosenman RH, Brand RJ, Jenkins D, et al:  Coronary heart disease in Western Collaborative Group Study: Final follow-up experience of 8½ years. JAMA 1975;233:872-877.Article
8.
Gofman JW, Young W, Tandy R:  Ischemic heart disease, atherosclerosis and longevity. Circulation 1966;34:679-697.Article
9.
Medalie JH, Kahn HA, Neufeld HN, et al:  Five-year myocardial infarction incidence: II. Association of single variables to age and birthplace. J Chronic Dis 1973;26:325-349.Article
10.
Miller NE, Thella DS, Førde OH, et al:  The Tromsø Heart Study: High density lipoprotein and coronary heart disease: A prospective case-control study. Lancet 1977;1:965-967.Article
11.
Gofman JW, Hanig M, Jones HM, et al:  Evaluation of serum lipoprotein and cholesterol measurements as predictors of clinical complications of atherosclerosis. Circulation 1956;14:691-742.Article
12.
Cassel JC:  Evans County cardiovascular and cerebrovascular epidemiologic study. Arch Intern Med 1971;128:883-985.Article
13.
Lawry EY, Mann GV, Peterson A, et al:  Cholesterol and beta lipoproteins in the serums of Americans: Well persons and those with coronary heart disease. Am J Med 1957;22:605-623.Article
14.
Fredrickson DS, Levy RI, Lees RS:  Fat transport and lipoproteins—an integrated approach to mechanisms and disorders. N Engl J Med 1967;276:34-44, 94-103, 148-156, 215-225, 273-281.Article
15.
Shurtleff D:  Some characteristics related to the incidence of cardiovascular disease and death: Framingham Study, 18-year follow-up , in Kannel WB, Gordon T (eds): The Framingham Study. US Government Printing Office, 1974.
16.
Walker SH, Duncan DB:  Estimation of the probability of an event as a function of several independent variables. Biometrika 1967;54:167-179.Article
17.
Glueck CJ, Gartside P, Fallat RW, et al:  Longevity syndromes: Familial hypobeta and familial hyperalpha lipoproteinemia. J Lab Clin Med 1976;88:941-957.
18.
Rossner S, Kjellin KG, Mettinger KL, et al:  Normal serum cholesterol but low HDL cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet 1978;1:577-579.Article
19.
Bradby GVH, Valente AJ, Walton KW:  Serum high-density lipoproteins in peripheral vascular diseases. Lancet 1978;2:1271-1274.Article
20.
Kannel WB, Gordon T, Dawber TR:  Role of lipids in the development of brain infarction: The Framingham Study. Stroke 1974;5:679-685.Article
21.
Kagan A, Paffer JS, Rhoads GG:  Factors related to stroke incidence in Hawaii Japanese: The Honolulu Heart Study. Stroke 1980;11:14-21.Article
22.
Ducimitiere P, Eschwege E, Richard J, et al:  Relationship of glucose tolerance of prevalence of ECG abnormalities and to annual mortality from cardiovascular disease: The Paris Prospective Study. J Chronic Dis 1979;32:759-766.Article
23.
Hawthorne VM, Gilmour WH:  Relationship of glucose to prevalence of ECG abnormalities at baseline and to six-year mortality in Scottish males aged 45-64 years. J Chronic Dis 1979;32:787-796.Article
24.
Beaglehole R, Foulkes MA, Prior IAM, et al:  Cholesterol and mortality in New Zealand Maoris. Br Med J 1980;1:285-287.Article
25.
McGee D, Gordon T:  The results of the Framingham Study applied to four other U.S.-based epidemiologic studies of cardiovascular disease , in Kannel WB, Gordon T (eds): The Framingham Study. US Government Printing Office, 1976.
26.
Rose G, Shipley MJ:  Plasma lipids and mortality: A source of error. Lancet 1980;1:523-526.Article
×